Copyright © Inderes 2011 - present. All rights reserved.
Logga in för att få aviseringar
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

BBS-Bioactive Bone Substitutes

3 910 följer bolaget
Översikt
Investerarkonsensus
Alla
Analys
Webcasts
Pressmeddelanden
VisarAlla typer av innehåll
Regulatoriskt pressmeddelande2025-03-05 12:30

BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2025-02-20 19:00

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2025-02-17 11:15

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt

BBS-Bioactive Bone Substitutes

Välkommen med i Inderes community!

Skapa ett gratis användarkonto och försäkra dig om att inte missa några börsnyheter av intresse för precis dig!

Inderes användarkonto
Ger dig möjlighet att följa bolag och beställa notifikationer
Tillgång till analytikerkommentarer och rekommendationer
Tillgång till vårt aktiescreeningsverktyg och andra populära verktyg
Skapa användarkonto
Regulatoriskt pressmeddelande2025-02-12 15:00

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2025-02-10 07:00

BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2025-02-06 13:00

BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2025-01-31 14:30

BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-12-18 12:00

Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-12-18 11:00

BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-12-13 11:00

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-12-13 07:30

BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations

BBS-Bioactive Bone Substitutes
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Video2024-12-02 14:00

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBBS-Bioactive Bone SubstitutesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Regulatoriskt pressmeddelande2024-11-29 14:30

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-11-29 14:20

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-11-29 13:00

BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-11-26 15:00

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-11-22 17:05

BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-11-22 17:00

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-11-14 12:00

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatoriskt pressmeddelande2024-11-07 11:00

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

Sekretessinställningar

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.